Rafael Rosell
Instituto Oncológico Dr. Rosell(ES)Hospital Universitario Dexeus(ES)Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol(ES)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group(2008)2,629 cited
- → Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer(2017)2,413 cited
- → Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1(2004)1,720 cited
- → Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2(2004)1,715 cited
- → Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial(2006)1,580 cited
- → Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry